Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 547 shares (to pay taxes)
  2. 4 Grant or award CHIEF OPERATING OFFICER acquired 1,048 shares (grant or award)
  3. 4 Grant or award CHIEF ACCOUNTING OFFICER acquired 703 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 20,000 shares (grant or award)
  11. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 282 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 5,446 shares (to pay taxes)
  19. 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 1,240 shares (to pay taxes)
  20. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,047 shares (to pay taxes)

Page 13 of 20 · 386 filings